CUSIP: 14888D109
Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,411,590
-
Share change
-
-539,921
-
Total reported value
-
$13,893,000
-
Price per share
-
$3.13
-
Number of holders
-
30
-
Value change
-
-$2,869,494
-
Number of buys
-
6
-
Number of sells
-
18
Quarterly Holders Quick Answers
What is CUSIP 14888D109?
CUSIP 14888D109 identifies CBIO - CATALYST BIOSCIENCES INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2016
-
Previous quarter:
Q3 2015
Recent filing periods for CUSIP 14888D109:
Institutional Holders of CATALYST BIOSCIENCES INC - COM (CBIO) as of Q4 2015
As of 31 Dec 2015,
CATALYST BIOSCIENCES INC - COM (CBIO) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,411,590 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., BVF INC/IL, NEA Management Company, LLC, UBS Group AG, VANGUARD GROUP INC, DG Capital Management, LLC, BlackRock Institutional Trust Company, N.A., Colorado Capital Management, Inc., RENAISSANCE TECHNOLOGIES LLC, and D. E. Shaw & Co., Inc..
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.